Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Inflammatory Bowel Diseases

  Free Subscription


30.12.2018

1 Aliment Pharmacol Ther
1 Clin Gastroenterol Hepatol
2 Gastroenterology
4 Gut
4 Inflamm Bowel Dis
4 J Crohns Colitis
4 Scand J Gastroenterol


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Aliment Pharmacol Ther

  1. LUCIDARME C, Petitcollin A, Brochard C, Siproudhis L, et al
    Predictors of relapse following infliximab de-escalation in patients with inflammatory bowel disease: the value of a strategy based on therapeutic drug monitoring.
    Aliment Pharmacol Ther. 2019;49:147-154.
    PubMed     Text format     Abstract available


    Clin Gastroenterol Hepatol

  2. RESTELLINI S, Chao CY, Martel M, Barkun A, et al
    Clinical Parameters Correlate With Endoscopic Activity of Ulcerative Colitis-a Systematic Review.
    Clin Gastroenterol Hepatol. 2018 Dec 21. pii: S1542-3565(18)31397.
    PubMed     Text format     Abstract available


    Gastroenterology

  3. SINGH S, Feuerstein JD, Binion DG, Tremaine WJ, et al
    American Gastroenterological Association Technical Review on the Management of Mild to Moderate Ulcerative Colitis.
    Gastroenterology. 2018 Dec 18. pii: S0016-5085(18)35406.
    PubMed     Text format     Abstract available

  4. KO CW, Singh S, Feuerstein JD, Falck-Ytter C, et al
    American Gastroenterological Association Institute Guideline on the Management of Mild-Moderate Ulcerative Colitis.
    Gastroenterology. 2018 Dec 18. pii: S0016-5085(18)35407.
    PubMed     Text format    


    Gut

  5. IACUCCI M, Furfaro F, Matsumoto T, Uraoka T, et al
    Advanced endoscopic techniques in the assessment of inflammatory bowel disease: new technology, new era.
    Gut. 2018 Dec 22. pii: gutjnl-2017-315235. doi: 10.1136/gutjnl-2017-315235.
    PubMed     Text format     Abstract available

  6. ROGLER G
    Mechanism of action of vedolizumab: do we really understand it?
    Gut. 2019;68:4-5.
    PubMed     Text format    

  7. HUTFLESS S, Wenning GK
    Which way does the axis tip? IBD increases the risk of Parkinson's disease.
    Gut. 2019;68:3.
    PubMed     Text format    

  8. GOUYNOU C, Pouillon L, Rousseau H, Zallot C, et al
    Early changes in the pharmacokinetic profile of vedolizumab-treated patients with IBD may predict response after dose optimisation.
    Gut. 2019;68:178-179.
    PubMed     Text format    


    Inflamm Bowel Dis

  9. LIN SC, Goldowsky A, Papamichael K, Cheifetz AS, et al
    The Treatment of Inflammatory Bowel Disease in Patients With a History of Malignancy.
    Inflamm Bowel Dis. 2018 Dec 22. pii: 5257774. doi: 10.1093.
    PubMed     Text format     Abstract available

  10. MACALUSO FS, Maida M, Ventimiglia M, Renna S, et al
    Factors Affecting Clinical and Endoscopic Outcomes of Placebo Arm in Trials of Biologics and Small Molecule Drugs in Ulcerative Colitis: A Meta-Analysis.
    Inflamm Bowel Dis. 2018 Dec 22. pii: 5257772. doi: 10.1093.
    PubMed     Text format     Abstract available

  11. HOOPER KM, Barlow PG, Henderson P, Stevens C, et al
    Interactions Between Autophagy and the Unfolded Protein Response: Implications for Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2018 Dec 24. pii: 5259659. doi: 10.1093.
    PubMed     Text format     Abstract available

  12. BARNES EL, Long MD, Kappelman MD, Martin CF, et al
    High Patient Activation Is Associated With Remission in Patients With Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2018 Dec 22. pii: 5257738. doi: 10.1093.
    PubMed     Text format     Abstract available


    J Crohns Colitis

  13. BEMELMAN WA, Warusavitarne J, Sampietro GM, Serclova Z, et al
    ECCO-ESCP Consensus on Surgery for Crohn's Disease.
    J Crohns Colitis. 2018;12:1-16.
    PubMed     Text format    

  14. BOYAPATI RK, Ho GT, Satsangi J
    Top-down in the Long Term in Crohn's Disease.
    J Crohns Colitis. 2018;12:513-514.
    PubMed     Text format    

  15. BEMELMAN WA
    Evolving Role of IBD Surgery.
    J Crohns Colitis. 2018;12:1005-1007.
    PubMed     Text format    

  16. SAMAAN MA, Forsyth K, Segal JP, de Jong D, et al
    Current Practices in Ileal Pouch Surveillance for Patients with Ulcerative Colitis: A Multinational, Retrospective Cohort Study.
    J Crohns Colitis. 2018 Dec 24. pii: 5259264. doi: 10.1093.
    PubMed     Text format     Abstract available


    Scand J Gastroenterol

  17. LI H, Gong Y, Xie Y, Sun Q, et al
    Clostridium butyricum protects the epithelial barrier by maintaining tight junction protein expression and regulating microflora in a murine model of dextran sodium sulfate-induced colitis.
    Scand J Gastroenterol. 2018;53:1031-1042.
    PubMed     Text format     Abstract available

  18. VERSTOCKT B, Vermeire S, Van Assche G, Ferrante M, et al
    When IBD is not IBD.
    Scand J Gastroenterol. 2018;53:1085-1088.
    PubMed     Text format     Abstract available

  19. SEGAL JP, Penez L, Mohsen Elkady S, Worley GHT, et al
    Long term outcomes of initial infliximab therapy for inflammatory pouch pathology: a multi-Centre retrospective study.
    Scand J Gastroenterol. 2018;53:1051-1058.
    PubMed     Text format     Abstract available

  20. JUDIT BERES N, Kiss Z, Muller KE, Cseh A, et al
    Role of microRNA-223 in the regulation of poly(ADP-ribose) polymerase in pediatric patients with Crohn's disease.
    Scand J Gastroenterol. 2018;53:1066-1073.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Inflammatory Bowel Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: